![]() |
市场调查报告书
商品编码
1828117
2025年全球胎儿监护市场报告Fetal Monitoring Global Market Report 2025 |
近年来,胎儿监护市场规模强劲成长,从2024年的38亿美元增加至2025年的40.5亿美元,复合年增长率为6.4%。预测期内的增长可归因于产妇年龄增长、妊娠併发症盛行率高、人们对产前护理的认识和重视程度不断提高、政府在母婴健康方面的倡议以及剖腹产率的上升。
预计未来几年胎儿监护市场规模将强劲成长,到2029年将达到56.9亿美元,复合年增长率为8.9%。预测期内的成长可归因于高风险怀孕的增加、远端医疗和远距监护趋势、对非侵入性监护解决方案的关注、协作研发以及以患者为中心的产妇护理方法。预测期内的主要趋势包括无线和穿戴式胎儿监护设备、人工智慧 (AI) 与胎儿监护的整合、远距胎儿监护服务、对非侵入性监护技术的关注以及可携式和手持式胎儿监护设备。
胎儿监护是指医护人员使用专门的设备监测分娩过程中母亲的宫缩和胎儿心率。这个监测过程提供了重要讯息,指导医护人员确定分娩过程中是否需要介入。
胎儿监测的主要产品类型包括超音波设备、电子母胎胎儿分娩监视器、子宫收缩监视器、胎儿电极、胎儿多普勒仪、遥测设备、配件和耗材。超音波诊断设备一种医学影像技术,利用高频声波产生人体内部影像。终端使用者可透过侵入式和非侵入式方法使用这些服务,进行产时胎儿监护、产前胎儿监护,以及诊断实验室、医院、诊所和其他医疗机构的胎儿监护。
2025年春季美国关税突然上调及其引发的贸易摩擦,对医疗设备领域产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供胎儿监护光学市场统计数据,包括全球市场规模、区域份额、胎儿监护光学市场份额竞争对手、详细的胎儿监护光学市场细分、市场趋势和商机,以及您在胎儿监护光学行业取得成功所需的数据。本胎儿监护光学市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年的预测成长率为8.9%,较我们先前对该市场的预测略有下降0.2%。这一下降主要源于美国与其他国家之间关税的影响,这可能会导致螺旋电极组件和ST段分析演算法的供应链中断,从而直接影响美国,因为这些组件和演算法主要来自以色列和荷兰等关键地区。
胎儿监护市场可望成长,这主要得益于早产率的上升。怀孕37週前的早产是一个令人担忧的问题,因为它与婴儿死亡率和身体残疾密切相关。医疗保健提供者利用胎儿监护设备持续监测胎心率和产妇宫缩等参数,以便在分娩过程中及时介入。随着早产率的上升,医院和诊所对胎儿监护设备的需求也上升。例如,截至2022年11月,世界卫生组织 (WHO) 报告称,每年约有1500万例早产,占新生儿总数的十分之一以上。因此,早产的普遍性正在推动胎儿监护市场的成长。
预计未来不断增长的医疗保健支出将推动胎儿监护市场扩张。医疗保健支出包括国家、政府、组织和个人为医疗保健相关产品和服务分配的总资源。这种支出的成长在胎儿监护市场的成长中发挥关键作用,因为它促进了技术进步、提高了可近性、支持了研发倡议,并推动了母胎护理品质的整体改善。例如,2022 年 12 月,美国联邦机构医疗保险和医疗补助服务中心报告称,医疗保健支出将增加 4.1%,到 2022 年达到 4.5 兆美元,超过 2021 年 3.2% 的增幅。因此,医疗保健支出的增加是推动胎儿监护市场向前发展的关键因素。
胎儿监护市场的主要企业处于开发最尖端科技的前沿,例如基于人工智慧的胎儿评估平台,以服务更大的基本客群、推动销售并增加收益。基于人工智慧的胎儿评估平台利用人工智慧 (AI) 演算法和计算技术来分析和解释与怀孕期间胎儿健康相关的数据。例如,2023 年 8 月,美国周产期软体解决方案供应商 PeriGen Inc. 推出了其 LaborWatch 平台。作为一个开创性的平台,LaborWatch 透过快速透明地向医院领导通报产妇病情持续恶化,提高了分娩过程中病患的安全性。在美国唯一基于人工智慧的孕产妇和胎儿警报系统PeriWatch Vigilance 的支持下,LaborWatch 可以自主识别患者的异常状况,并在预定的时限内将通知传递给上级指挥系统。这种简化的流程使医院领导者能够迅速了解危急情况,LaborWatch 以其独特而有效的方法脱颖而出。
胎儿监护市场的主要企业正在采取策略伙伴关係方式,以提供从产前到分娩的更全面的孕期护理体验。策略伙伴关係是公司利用彼此的优势和资源,实现互利共赢的地方。 2022 年 3 月,总部位于荷兰的胎儿监护解决方案供应商荷兰皇家飞利浦公司与总部位于以色列的医疗设备供应商 Nuvo Group Ltd. 合作。根据这项伙伴关係,飞利浦将支持 Nuvo 开展试验计画,首先在科罗拉多开展一项农村试点试验计画,透过远距胎儿监护提高混合护理的可及性和依从性。这项伙伴关係表明了 Nuvo 致力于为患者、医疗保健提供者和付款人提供更全面的怀孕护理解决方案。
2022年7月,法国私募股权公司Arquimed SAS以11亿美元收购了Natus Medical Incorporated。此次收购旨在整合Natus Medical在神经诊断和神经病学解决方案方面的专业知识,增强Arquimed SAS的产品组合,并提升其医疗技术能力。 Natus Medical Incorporated是一家美国医疗设备製造商,为医疗保健专业人员提供广泛的产品和服务,专注于神经诊断、新生儿护理和听力筛检解决方案。
胎儿监护市场的主要企业包括荷兰皇家飞利浦公司、美敦力公司、西门子医疗股份公司、通用电气医疗集团、Neoventa Medical AB、Spacelabs Healthcare Inc.、Natus Medical Incorporated、EDAN Instruments Inc.、深圳科曼医疗器材有限公司、Contec Medical Systems Co.Ltd.、Bionet Co.Ltd Corporation.L. LLC、Cooper Surgical Inc.、Dixion Vertrieb medizinischer Gerate GmbH、Dragerwerk AG & Co.KGaA、Fisher & Paykel Healthcare Corporation Limited、Huntleigh Healthcare Limited、Masimo Corporation、Mediana Co.Ltd.、迈瑞医疗设备国际有限公司,亦位于此股份有限公司、OBMedical Company、Generi Inc.,有限公司
2024年,北美是胎儿监护市场最大的地区。预计亚太地区将成为胎儿监护全球市场报告预测期内成长最快的地区。胎儿监护市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。
胎儿监护市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
胎儿监护市场包括提供持续电子胎儿监护、中央胎儿监护和间歇性听诊的营业单位所获得的收益。市场规模包括服务提供者销售或包含在其服务产品中的相关产品的价值。胎儿监护市场还包括宫缩力计、胎儿头皮电极和子宫内压力导管的销售。该市场中的产品价值为“出厂价”,即产品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。
Fetal monitoring involves the utilization of specialized equipment by medical professionals to monitor both the mother's contractions and the fetus's heart rate during the birthing process. This monitoring process provides crucial information that guides medical professionals in determining whether intervention is necessary during childbirth.
The primary product categories within fetal monitoring encompass ultrasound devices, electronic maternal or fetal monitors, uterine contraction monitors, fetal electrodes, fetal Doppler devices, telemetry devices, as well as accessories and consumables. Ultrasound devices, a form of medical imaging technology, generate images of the body's interior using high-frequency sound waves. These services employ both invasive and non-invasive methods and find applications in intrapartum fetal monitoring, antepartum fetal monitoring, and are utilized by end-users such as diagnostic laboratories, hospitals, clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The fetal monitoring market research report is one of a series of new reports from The Business Research Company that provides fetal monitoring optical components market statistics, including fetal monitoring optical components industry global market size, regional shares, competitors with a fetal monitoring optical components market share, detailed fetal monitoring optical components market segments, market trends and opportunities, and any further data you may need to thrive in the fetal monitoring optical components industry. This fetal monitoring optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fetal monitoring market size has grown strongly in recent years. It will grow from $3.8 billion in 2024 to $4.05 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing maternal age, high prevalence of pregnancy complications, rising awareness and emphasis on prenatal care, government initiatives for maternal and child health, and increasing cesarean section rates.
The fetal monitoring market size is expected to see strong growth in the next few years. It will grow to $5.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to a rise in high-risk pregnancies, telehealth and remote monitoring trends, focus on non-invasive monitoring solutions, collaborations for research and development, patient-centric approach in maternity care. Major trends in the forecast period include wireless and wearable fetal monitoring devices, integration of artificial intelligence (AI) in fetal monitoring, remote fetal monitoring services, focus on non-invasive monitoring technologies, and portable and handheld fetal monitoring devices.
The forecast of 8.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for spiral electrode assemblies and ST-segment analysis algorithms, sourced from key regions such as Israel and the Netherlands, which could lead to delayed detection of fetal distress and increased obstetric expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The fetal monitoring market is poised for growth, primarily propelled by the increasing prevalence of preterm births. Preterm births, occurring before the 37th week of pregnancy, are a significant concern due to their association with infant mortality and disability. Healthcare providers utilize fetal monitoring devices to continuously monitor parameters such as fetal heart rate and the mother's contractions, enabling timely interventions during delivery. The demand for fetal monitoring devices in hospitals and clinics is on the rise with the increasing occurrence of preterm deliveries. For example, as of November 2022, the World Health Organization reported an estimated 15 million premature births annually, accounting for over one in ten newborns. Consequently, the prevalence of preterm births acts as a driving force for the growth of the fetal monitoring market.
The increasing expenditure on healthcare is anticipated to accelerate the expansion of the fetal monitoring market in the future. Healthcare expenditure encompasses the total resources-both financial and non-financial-allocated by a country, government, organization, or individual towards healthcare-related products and services. This rising expenditure plays a vital role in the growth of the fetal monitoring market by facilitating technological advancements, enhancing accessibility, supporting research and development initiatives, and driving overall improvements in maternal and fetal healthcare quality. For example, in December 2022, the Centers for Medicare & Medicaid Services, a federal agency in the U.S., reported a 4.1% increase in healthcare spending, reaching $4.5 trillion in 2022, outpacing the 3.2% growth seen in 2021. Consequently, the growing healthcare expenditure is a key factor propelling the fetal monitoring market forward.
Major companies within the fetal monitoring market are at the forefront of developing cutting-edge technologies, such as AI-based fetal assessment platforms, aiming to cater to larger customer bases, boost sales, and increase revenue. An AI-based fetal assessment platform utilizes artificial intelligence (AI) algorithms and computational techniques to analyze and interpret data related to fetal well-being during pregnancy. For example, in August 2023, PeriGen Inc., a US-based provider of perinatal software solutions, introduced the LaborWatch platform. Distinguished as a groundbreaking platform, LaborWatch enhances intrapartum patient safety by promptly and transparently alerting hospital leadership to persistent deteriorating trends in laboring patients. Fueled by PeriWatch Vigilance, the exclusive AI-based maternal-fetal early warning system in the United States, LaborWatch autonomously identifies abnormal patient conditions and communicates notifications to the chain of command within a predefined timeframe. This streamlined process ensures that hospital leaders are promptly informed about critical situations, setting LaborWatch apart with its unique and effective approach.
Major companies in the fetal monitoring market are adopting a strategic partnership approach to offer a more comprehensive pregnancy care experience, spanning from the prenatal phase through labor and delivery. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. In March 2022, Royal Philips, a Netherlands-based provider of fetal monitoring solutions, formed a partnership with Nuvo Group Ltd., an Israel-based provider of medical devices. This collaboration involves Philips assisting Nuvo in conducting pilot programs for remote fetal monitoring to enhance accessibility and adherence to prescribed care, starting with a pilot program in rural Colorado. This partnership signifies Nuvo's commitment to delivering more comprehensive pregnancy care solutions to patients, providers, and payers.
In July 2022, Archimed SAS, a private equity firm based in France, purchased Natus Medical Incorporated for $1.1 billion. This acquisition is intended to strengthen Archimed SAS's portfolio by incorporating Natus Medical's knowledge in neurodiagnostics and neurology solutions, thereby broadening their healthcare technology capabilities. Natus Medical Incorporated, a medical device company located in the United States, provides an extensive array of products and services centered around neurodiagnostic, newborn care, and hearing screening solutions for healthcare professionals.
Major companies operating in the fetal monitoring market include Koninklijke Philips N.V., Medtronic plc, Siemens Healthineers AG, GE Healthcare Company, Neoventa Medical AB, Spacelabs Healthcare Inc., Natus Medical Incorporated, EDAN Instruments Inc., Shenzhen Comen Medical Instruments Co. Ltd., Contec Medical Systems Co. Ltd., Bionet Co. Ltd., Analogic Corporation, Atom Medical Corporation, Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Cooper Surgical Inc., Dixion Vertrieb medizinischer Gerate GmbH, Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, Huntleigh Healthcare Limited, Masimo Corporation, Mediana Co. Ltd., Mindray Medical International Limited, Nonin Medical Inc., OBMedical Company, PeriGen Inc., Sunray Medical Apparatus Co. Ltd.
North America was the largest region in the fetal monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global fetal monitoring market report forecast period. The regions covered in the fetal monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the fetal monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The fetal monitoring market includes revenues earned by entities by providing continuous electronic fetal monitoring, central fetal monitoring and intermittent auscultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The fetal monitoring market also includes sales of tocodynamometer, fetal scalp electrode and intrauterine pressure catheter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fetal Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fetal monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for fetal monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fetal monitoring market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.